@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_head { this: np:hasAssertion dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_assertion; np:hasProvenance dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_provenance; np:hasPublicationInfo dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_publicationInfo; a np:Nanopublication . dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_assertion a np:Assertion . dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_provenance a np:Provenance . dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_publicationInfo a np:PublicationInfo . } dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_assertion { miriam-gene:7072 a ncit:C16612 . lld:C1306459 a ncit:C7057 . dgn-gda:DGNbcf1aee5bb1bd372ffbb37b13df6783f sio:SIO_000628 miriam-gene:7072, lld:C1306459; a sio:SIO_001121 . } dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_provenance { dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_assertion dcterms:description "[It was shown that, in NSCLC: (1) tumor stroma inflammatory cells are mainly TIL (approximately 2/3) (among them, 80 % are T-cells) and TAM (approximately 1/3), with almost no natural killer (NK) cells, and a few dentritic cells; (2) TAM and TIL are poorly replicating, but mainly recruited to the tumor stroma; (3) more than half TAM show an antibody-dependent cytotoxic potential, and one third of T-cells are TIA-1 positive CD8 activated cytotoxic lymphocytes; (4) cancer cells from only a few tumor express HLA class I and II antigens; (5) TAM production of cytotoxic cytokines [interleukin-1alpha (IL-1alpha), IL-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha)] and of transforming growth factor-beta1 (TGF-beta1) is low, in contrast to their strong release of platelet-derived growth factor (PDGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:12434133; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP737291.RAP1KUQgpQN-q5NLI9TgOd_V8StBOOQmzUlPybM8YHjnQ130_publicationInfo { this: dcterms:created "2015-08-25T14:45:04+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }